Atherosclerosis
Volume 168, Issue 1 , Pages 65-72, May 2003

Vitamin C, diclophenac, and l-arginine protect endothelium-dependent vasodilation against elevated circulating fatty acid levels in humans

  • Peter Steer

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-18-611-3632
  • ,
  • Jonas Millgård

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
  • ,
  • Samar Basu

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
  • ,
  • Hans Lithell

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
  • ,
  • Bengt Vessby

      Affiliations

    • Department of Public Health and Caring Sciences, University Hospital, SE-75185 Uppsala, Sweden
  • ,
  • Christian Berne

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden
  • ,
  • Lars Lind

      Affiliations

    • Department of Medical Sciences/Internal Medicine, University Hospital, SE-75185 Uppsala, Sweden

Received 29 April 2002; received in revised form 23 December 2002; accepted 16 January 2003.

Abstract 

An acute elevation of circulating non-esterified fatty acids (NEFAs) has previously been shown to impair endothelium-dependent vasodilation (EDV). In this study, we investigated if local administration of vitamin C (n=8, 18 mg/min), l-arginine (n=8, 12.5 mg/min), or the cyclooxygenase (COX) inhibitor diclophenac (n=8, 0.5 mg/min) can counteract the endothelial dysfunction seen during infusion of Intralipid® plus heparin (n=10). EDV and endothelium-independent vasodilation (EIDV) were studied in the forearm after local administration of methacholine chloride (Mch; 2 and 4 μg/min) and sodium nitroprusside (SNP; 5 and 10 μg/min). Forearm blood flow (FBF) was determined with venous occlusion plethysmography. Intralipid® and heparin increased circulating NEFA levels sevenfold and impaired EDV (P<0.001 vs baseline). Concomitant administration of l-arginine or diclophenac abolished the NEFA-induced impairment in EDV. Concomitant vitamin C administration actually improved EDV (P<0.05 vs baseline). NEFA elevation increased EIDV (P<0.01), but this effect was not significant after l-arginine or diclophenac infusions. In conclusion, an acute elevation of circulating NEFAs led to impaired EDV. Administration of l-arginine, vitamin C or COX inhibition abolished this effect, suggesting that NEFAs might interact with endothelial vasodilatory function through multiple mechanisms.

Keywords:  Nitric oxide, Cyclooxygenase, Lipid peroxidation, Triglyceride and endothelium, Vasodilation, Fatty acid

Abbreviations:  ADMA, asymmetrical dimethylarginine, COX, cyclooxygenase, EDV, endothelium-dependent vasodilation, EIDV, endothelium-independent vasodilation, FBF, forearm blood flow, Mch, methacholine chloride, NEFA, non-esterified fatty acid, NO, nitric oxide, SNP, sodium nitroprusside, VSMC, vascular smooth muscle cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(03)00023-6

doi:10.1016/S0021-9150(03)00023-6

Atherosclerosis
Volume 168, Issue 1 , Pages 65-72, May 2003